Global Insomnia Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Insomnia Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Insomnia Medication report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insomnia Medication market is projected to reach US$ 3710.3 million in 2034, increasing from US$ 2921.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Adults and Kids are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insomnia Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insomnia Medication key manufacturers include Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc. Eisai, Merck, Pfizer are top 3 players and held % sales share in total in 2022.
Insomnia Medication can be divided into Nonbenzodiazepine Receptor Agonists, Benzodiazepine Receptor Agonists, The Selective Melatonin Receptor Agonist Ramelteon and Sedating Antidepressants, etc. Nonbenzodiazepine Receptor Agonists is the mainstream product in the market, accounting for % sales share globally in 2022.
Insomnia Medication is widely used in various fields, such as Adults and Kids, etc. Adults provides greatest supports to the Insomnia Medication industry development. In 2022, global % sales of Insomnia Medication went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insomnia Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Adults
Kids
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insomnia Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insomnia Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insomnia Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insomnia Medication introduction, etc. Insomnia Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insomnia Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Insomnia Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insomnia Medication key manufacturers include Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc. Eisai, Merck, Pfizer are top 3 players and held % sales share in total in 2022.
Insomnia Medication can be divided into Nonbenzodiazepine Receptor Agonists, Benzodiazepine Receptor Agonists, The Selective Melatonin Receptor Agonist Ramelteon and Sedating Antidepressants, etc. Nonbenzodiazepine Receptor Agonists is the mainstream product in the market, accounting for % sales share globally in 2022.
Insomnia Medication is widely used in various fields, such as Adults and Kids, etc. Adults provides greatest supports to the Insomnia Medication industry development. In 2022, global % sales of Insomnia Medication went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insomnia Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application
Adults
Kids
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insomnia Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insomnia Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insomnia Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insomnia Medication introduction, etc. Insomnia Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insomnia Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.